title: Should randomized clinical trials be required for proton radiotherapy?
authors.affiliation: Department of Radiation Oncology, Harvard Medical School, Boston, MA, USA.
authors.forename: Michael
authors.initials: M
authors.lastname: Goitein
authors.forename: James D
authors.initials: JD
authors.lastname: Cox
mesh_terms: D002813:Chondrosarcoma / Q000532:radiotherapy; D002817:Chordoma / Q000532:radiotherapy; D005134:Eye Neoplasms / Q000532:radiotherapy; D006258:Head and Neck Neoplasms / Q000532:radiotherapy; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000532:radiotherapy*; D011471:Prostatic Neoplasms / Q000532:radiotherapy; D061766:Proton Therapy; D011878:Radiotherapy / Q000191:economics / Q000379:methods; D016032:Randomized Controlled Trials as Topic; D019292:Skull Base Neoplasms / Q000532:radiotherapy; D011522:Protons
chemical_list: D011522:Protons